lemborexant
โ Previous: lefetamine | ๐ All Substances | ๐ Complete Table | Next: lenomorelin โ
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule IV |
| Reason | Controlled substance: Schedule IV |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule IV (DEA Controlled Substance List: Schedule IV) |
| Added to Database | December 30, 2025 |
| Source Last Updated | March 7, 2024 |
| GUID | 99c5799e-16af-4924-b6c1-dd324a89d128 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 0K5743G68X ยท CAS: 1369764-02-2
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C22H20F2N4O2 |
| Molecular Weight | 410.4 g/mol |
| IUPAC Name | cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide |
| InChIKey | MUGXRYIUWFITCP-PGRDOPGGSA-N |
๐ Complete Table | ๐ All Substances
Substance 496 of 880